Sealed Mobius® CellReady 3L Single-use Bioreactor made by Merck Millipore for cell cultures, from the Jenner Institute of the type used during the early development for the ChAdOx1 nCoV-19, Oxford/AstraZeneca COVID-19 vaccine Single-use desktop bioreactor 2010-2015
Rocking panel, with Flexsafe® cell bags, part of Biostat® bioreactor system, made by Satorius Stedim Biotech, used for growing PER.C6 cells for the early production of the Janssen Johnson & Johnson COVID-19 vaccine, 2020-2021 Rocking panel from bioreactor used during manufacture of the Janssen, Johnson & Johnson COVID-19 vaccine 2012
Microalgae bioreactor pilot unit tested at Berwick-upon-Tweed station in 2023 and 2024. The unit was created to test the feasibility of using microalgae bioreactors to capture carbon around stations, given the plant can be up to 400 times more efficient at capturing carbon dioxide than trees – by area and density. The purpose of the pilot was to prove that microalgae can be successfully grown outdoors in the UK climate without the need for temperature control, and crucially, the system was able to capture carbon on a small scale. Both objectives were clearly demonstrated over the course of the technology's trial period. Microalgae Bioreactor Pilot Unit 2023
Benchtop Biostat® B-DCU II fermenter/bioreactor, consisting of BioPAT DCU Tower display panel, Biostat® B-DCU II control panel, 10 litre Univessel® Glass flask and rubber mat made by Satorius Stedim Biotech, used for as cell expansion bioreactor or as virus production bioreactor for the early production of the Janssen Johnson & Johnson COVID-19 vaccine, 2020-2021 10 litre cell expansion bioreactor used in the production of the Janssen Johnson & Johnson COVID-19 vaccine 2015-2020